Kesler Norman & Wride’s Select Medical SEM Stock Holding History

Kesler Norman & Wride’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$190K	Buy	+11,536	New	+$190K	0.03%	270
2025 Q4	–	Sell	-24,233	Closed	-$457K	–	261
2025 Q3	$457K	Buy	+24,233	New	+$323K	0.09%	180
2025 Q2	–	Sell	-45,417	Closed	-$758K	–	229
2025 Q1	$758K	Buy	45,417 +21,184	+87%	+$390K	0.14%	152
2024 Q4	$457K	Buy	24,233 +3,255	+16%	+$62.8K	0.1%	175
2024 Q3	$394K	Buy	+20,978	New	+$402K	0.08%	192

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Kesler Norman & Wride's SEM Position: Q2 2026 in Review

Kesler Norman & Wride opened a new position in Select Medical (SEM) in Q2 2026: 11,536 shares worth $190K. The stake represents 0.03% of the portfolio and ranks #270 among its holdings. This is a return to the name: Kesler Norman & Wride previously reported a position in SEM as recently as Q3 2025.

Kesler Norman & Wride first reported a position in SEM in Q3 2024 and has held it in 5 quarters since. The position peaked at $758K in Q1 2025. 239 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Kesler Norman & Wride held 11,536 shares of Select Medical worth $190K as of Q2 2026.
Select Medical was a new Kesler Norman & Wride position in Q2 2026.
Select Medical made up 0.03% of Kesler Norman & Wride's portfolio in Q2 2026, its #270 holding.
Kesler Norman & Wride first reported a position in Select Medical in Q3 2024 and has held it in 5 quarters since.
Kesler Norman & Wride's Select Medical position peaked at $758K in Q1 2025.
239 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Kesler Norman & Wride's 13F filing for Q2 2026, filed 23 Jul 2026.